Research progress and quality markers prediction analysis of Dysosma versipellis
作者机构：Endocrine and Metabolic Disease CenterFirst Affiliated Hospitaland College of Clinical Medicine of Henan University of Science and TechnologyMedical Key Laboratory of Hereditary Rare Diseases of HenanLuoyang Sub-center of National Clinical Research Center for Metabolic DiseasesLuoyang 471000China Department of PharmacySuzhou TCM Hospital Affiliated to Nanjing University of Chinese MedicineSuzhou 215009China College of Traditional Chinese MedicineBeijing University of Traditional Chinese MedicineBeijing 100029China School of Health&Biomedical SciencesRMIT University–Bundoora CampusMelbourne 3083Australia School of Biological and Medical EngineeringBeihang UnivesityBeijing 100083China
出 版 物：《Traditional Medicine Research》 (TMR传统医学研究)
年 卷 期：2023年第8卷第3期
页 面：36-50页
学科分类：1008[医学-中药学(可授医学、理学学位)] 1006[医学-中西医结合] 100602[医学-中西医结合临床] 10[医学]
基 金：the National Natural Science foundation of China(No.82204938)
主 题：Dysosma versipellis lignans flavonoids chemical composition pharmacological activity toxicological effect quality marker podophyllotoxin kaempferol quercetin
摘 要：Dysosma versipellis is the rhizome of Bajiaolian in *** is a unique medicinal plant in China and it was the first to be recorded in Shennong’s Classic of Materia Medica(unknown author,25–220 C.E.).It has complex chemical components as well as complex,pharmacological and toxicological effects are *** on the recent research progress,the chemical constituents,pharmacological activities and toxicological effects of Dysosma versipellis were *** with the core concept of quality markers of traditional Chinese medicine,the prediction and analysis were carried out from the aspects of phytogenetics and the source pathway of specific chemical constituents,traditional medicinal properties,traditional efficacy,chemical composition measurability,blood components,and pharmacokinetics,in order to provide reference for further study of Dysosma versipellis.
维普期刊数据库
